Company / Interest Expense
CHINA PHARMA HOLDINGS, INC. Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$27.3K
FY2025
5-year range
$27.3K / $434.6K
FY2021-FY2025
Trend
-10.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has fluctuated over the past 10 years, ranging from -$1M in FY2016 to $849,557 in FY2017.
Based on SEC 10-K filings.
$27,272 in FY2025 with a 5-year CAGR of -39.0%.
Improved from $30,572 to $27,272 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -60.3%
- 5-Year CAGR
- -39.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -39.0%, indicating a declining trend.
- In FY2025, interest expense decreased 10.8% year-over-year.
- Peak interest expense was recorded in FY2017.
- Lowest interest expense in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.3K | -10.8% |
| FY2024 | $30.6K | +0.0% |
| FY2023 | $30.6K | -93.0% |
| FY2022 | $434.6K | +47.7% |
| FY2021 | $294.2K | -8.6% |
| FY2020 | $321.7K | -28.7% |
| FY2019 | $451.3K | -16.3% |
| FY2018 | $539.3K | -36.5% |
| FY2017 | $849.6K | +172.9% |
| FY2016 | -$1.2M | -248.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026